Skip to main content
padlock icon - secure page this page is secure

XBP-1 and the UPRosome: Mastering Secretory Cell Function

Buy Article:

$68.00 + tax (Refund Policy)

A unique feature of secretory cells is the proliferation of the endoplasmic reticulum (ER) and Golgi network. The high demand imposed by protein synthesis and folding in secretory cells constitutes an endogenous source of stress due to the accumulation of toxic misfolded intermediaries. Adaptation to ER stress is mediated by the activation of a complex signal transduction pathway known as the unfolded protein response (UPR). Evidence from genetic manipulation of the UPR supports the notion that components of the pathway are essential to sustain the function of secretory cells. Expression of the UPR transcriptional factor X-Box binding protein-1 (XBP-1) is essential for the proper function of plasma B cells and exocrine cells of pancreas and salivary glands. Active XBP-1 is generated by the direct processing of its mRNA by the ER stress sensor IRE1α through the formation of a complex signaling platform at the ER membrane, here termed as UPRosome. XBP-1 controls the expression of genes involved in almost every aspect of the secretory pathway including folding, protein quality control, ER translocation, glycosylation, and remodeling of ER and Golgi structure. In this article we discuss recent advances in understanding the mechanisms through which XBP-1 controls secretory cell function and the possible involvement of this pathway in disease conditions related to irreversible ER damage. Current therapeutic strategies to modulate ER function are also discussed.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Publication date: February 1, 2008

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more